Liquid biopsy: novel technologies and clinical applications
Beteiligte Einrichtungen
Abstract
"Liquid biopsy" was introduced as a new diagnostic concept in 2010 for the analysis of circulating tumor cells (CTCs) and has been now extended to material (in particular DNA) released by tumor cells in the peripheral blood of cancer patients. Over the past decade, various methods have been developed to detect CTCs and ctDNA in the peripheral blood of cancer patients.
Bibliografische Daten
Originalsprache | Englisch |
---|---|
ISSN | 1434-6621 |
DOIs | |
Status | Veröffentlicht - 25.02.2019 |
PubMed | 30465714 |
---|